You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 25, 2025

Details for Patent: 10,537,520


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,537,520 protect, and when does it expire?

Patent 10,537,520 protects IVRA and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 10,537,520
Title:Stable liquid formulations of melphalan
Abstract:The present invention relates to stable, liquid parenteral formulations of Melphalan or pharmaceutically acceptable salts thereof. Further this invention also describes process of preparing such formulations.
Inventor(s):Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
Assignee:Leiutis Pharmaceutials LLP
Application Number:US15/739,034
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Case Study of United States Patent 10,537,520

Introduction

When analyzing a U.S. patent, understanding the scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the specifics of United States Patent 10,537,520, using general principles and tools available for patent analysis.

Understanding Patent Claims

Patent claims define the scope of the invention and are the legal boundaries of what is protected by the patent. They are typically divided into independent and dependent claims, with independent claims standing alone and dependent claims referring back to another claim[3].

The Importance of Inventorship

Before diving into the claims, it is essential to ensure that the inventors listed on the patent are the "true and only" inventors. U.S. patent law requires that only those who conceived the idea and reduced it to practice be listed as inventors. Incorrect or incomplete identification of inventors can lead to challenges and potentially render the patent unenforceable[2].

Tools for Patent Search and Analysis

Several tools are available for searching and analyzing patents:

  • Patent Public Search: This tool provides enhanced access to prior art and is a powerful resource for conducting thorough patent searches[1].
  • Global Dossier: This service allows users to view the patent family for a specific application, including related applications from participating IP Offices[1].
  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques[1].

Analyzing United States Patent 10,537,520

Patent Details

To analyze the patent, start by retrieving the patent document from the USPTO database or other patent search tools.

  • Title and Abstract: The title and abstract provide a brief overview of the invention. This helps in understanding the general scope of the patent.
  • Claims: The claims section is the most critical part of the patent. Here, you will find the detailed legal description of the invention.
    • Independent Claims: These claims define the broadest scope of the invention.
    • Dependent Claims: These claims narrow down the invention by adding specific limitations to the independent claims.

Claim Construction

Claim construction involves interpreting the meaning of the claims. This process is crucial for determining the scope of the patent. Here are some steps to follow:

  • Identify Key Terms: Determine the meaning of key terms used in the claims. This may involve looking at the specification and drawings for context.
  • Determine Claim Scope: Understand how the claims interact with each other. Dependent claims can provide additional specificity to independent claims[3].

Prior Art and Patentability

To assess the validity of the patent, it is essential to evaluate the prior art cited during the patent examination process. Tools like the Common Citation Document (CCD) can help consolidate prior art citations from multiple offices, providing a comprehensive view of the prior art landscape[1].

Patent Scope Measurements

The USPTO provides datasets and research papers that help in understanding patent scope. For example, the Patent Claims Research Dataset contains detailed information on claims from U.S. patents and applications, including claim-level statistics and document-level statistics. This dataset can help in analyzing the scope and complexity of the patent claims[3].

Legal Considerations

Patent eligibility under 35 U.S.C. § 101 is a critical aspect to consider. The Supreme Court and the Federal Circuit have established guidelines to determine whether claims are directed to patent-ineligible concepts such as abstract ideas, laws of nature, or natural phenomena. The Mayo/Alice framework is commonly used for this analysis[5].

Practical Steps for Analysis

  1. Retrieve the Patent Document:
    • Use the USPTO's Patent Public Search tool or other databases to retrieve the full text of the patent.
  2. Review the Claims:
    • Identify independent and dependent claims.
    • Analyze the key terms and their meanings within the context of the specification and drawings.
  3. Evaluate Prior Art:
    • Use tools like the CCD to review prior art citations.
    • Assess how the prior art affects the patentability of the claims.
  4. Assess Patent Eligibility:
    • Apply the Mayo/Alice framework to determine if the claims are directed to patent-ineligible concepts.
  5. Consult Additional Resources:
    • Utilize PTRCs or the USPTO Public Search Facility for additional guidance and resources.

Example Analysis

For United States Patent 10,537,520, let's assume it is a utility patent for a new software algorithm.

  • Claims Analysis:
    • Independent Claim 1 might describe the broadest scope of the algorithm.
    • Dependent Claim 2 might add specific limitations, such as the use of a particular data structure.
  • Prior Art Review:
    • Use the CCD to consolidate prior art citations from various offices.
    • Evaluate how the prior art affects the novelty and non-obviousness of the claims.
  • Patent Eligibility:
    • Apply the Mayo/Alice framework to determine if the claims are directed to an abstract idea.
    • If so, assess whether the additional elements transform the nature of the claim into a patent-eligible application.

Key Takeaways

  • Understand the Claims: The claims define the legal boundaries of the patent.
  • Evaluate Prior Art: Prior art citations are crucial for determining patentability.
  • Assess Patent Eligibility: Ensure the claims are not directed to patent-ineligible concepts.
  • Use Available Tools: Utilize tools like the Patent Public Search, Global Dossier, and CCD for comprehensive analysis.
  • Consult Experts: If necessary, consult with patent attorneys or experts at PTRCs for additional guidance.

FAQs

Q: How do I determine the true and only inventors for a U.S. patent? A: The true and only inventors are those who conceived the idea and reduced it to practice. This involves a two-step process: conception of the idea and reduction of the idea to practice[2].

Q: What is the purpose of the Common Citation Document (CCD)? A: The CCD provides single-point access to up-to-date citation data relating to the patent applications of the IP5 Offices, consolidating prior art citations for the same invention[1].

Q: How do I assess the patent eligibility of a claim under 35 U.S.C. § 101? A: Use the Mayo/Alice framework to determine if the claims are directed to patent-ineligible concepts such as abstract ideas, laws of nature, or natural phenomena[5].

Q: What resources are available for conducting a thorough patent search? A: Resources include the Patent Public Search tool, Global Dossier, Patent and Trademark Resource Centers (PTRCs), and the USPTO Public Search Facility[1].

Q: Why is it important to analyze the scope and claims of a patent? A: Analyzing the scope and claims helps in determining the validity, enforceability, and potential impact of the patent on the market.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Determining Inventorship for US Patent Applications: https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf
  3. Patent Claims Research Dataset - USPTO: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Diversity in Patent Law: A Data Analysis: https://www.americanbar.org/groups/intellectual_property_law/publications/landslide/2020-21/september-october/diversity-patent-law-data-analysis-diversity-patent-practice-technology-background-region/
  5. ENFISH, LLC v. MICROSOFT CORPORATION: https://cafc.uscourts.gov/sites/default/files/opinions-orders/15-1244.Opinion.5-10-2016.1.PDF

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,537,520

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Apotex IVRA melphalan hydrochloride SOLUTION;INTRAVENOUS 217110-001 Aug 18, 2023 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,537,520

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2017002030 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.